April 21, 2023
The University of Cincinnati's Alberto Espay will present Parkinson's disease research at the American Academy of Neurology's annual meeting April 22-27 in Boston.
April 21, 2023
Local 12 and WCPO highlighted the Imvax trial being hosted at the University of Cincinnati that is testing the effectiveness of a personalized vaccine approach to fight deadly brain tumors.
April 24, 2023
The University of Cincinnati’s Paolo Palmisciano, MD, was part of an award-winning research team that examined how well a minimally invasive approach worked to limit vision and hearing loss in patients following brain tumor surgery and will present the research at the American Association of Neurological Surgeons annual scientific meeting.
April 26, 2023
WFMZ-TV in Allentown, Pennsylvania highlighted the University of Cincinnati's John Byrd and the Beat AML study testing personalized treatment for patients with acute myelogenous leukemia.
April 27, 2023
National outlets including U.S. News & World Report highlighted research presented by the University of Cincinnati's Alberto Espay on promising new treatments for Parkinson's disease.
April 28, 2023
The University of Cincinnati's Christopher T. Richards, MD, was a recent guest on the Know Stroke Podcast to discuss mobile stroke units and where research is headed to improve care.
May 2, 2023
University of Cincinnati cosmetic science expert Kelly Dobos was featured in a Vox article providing clarity on common questions about sunscreen.
May 3, 2023
WLWT spoke with the University of Cincinnati's Brandon Foreman about a clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.
May 3, 2023
The University of Cincinnati's Cosmetic Science program will launch a graduate certificate in hygienic manufacturing of cosmetic products beginning this fall.
May 5, 2023
The University of Cincinnati's Soma Sengupta was a co-first author on research published in Cell Reports Medicine New that found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.